ISRCTN12504151已完成未知
Warfarin Anticoagulation for liver Fibrosis in patients Transplanted for hepatitis C virus infection
Imperial College London (UK)0 个研究点目标入组 90 人开始时间: 2008年10月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
2015 Abstract results in https://doi.org/10.1016/S0168-8278(15)30165-3 1-year interim results presented at the International Liver Congress (added 05/09/2023) 2011 Thesis results in https://doi.org/10.25560/9479 1-year interim results (added 05/09/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Hepatitis C virus (HCV) infection
- •2. Aged over 17 years, either sex
- •3. Liver transplant within previous 4 months
- •4. Informed consent
排除标准
- •1. Patients requiring anticoagulation for existing clinical indications
- •2. Standard contraindications to anticoagulation (active peptic ulcer disease, past history of haemorrhagic stroke, thrombocytopaenia (platelets count less than 90 x10^9/L)
- •3. Large oesophageal varices persisting post-transplant
- •4. Cerebrovascular abnormalities on pre-transplant computed tomography (CT) scan
- •5. Human immunodeficiency virus (HIV) antibody positive
研究者
相似试验
进行中（未招募）
1 期
Warfarin Anticoagualtion for liver fibrosis in patients transplanted for hepatitis C virus infection. - WAFT-CEUCTR2006-006221-77-GBClinical Research office, Faculty of Medicine, Imperial College London10
已完成
2 期
Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus InfectionLiver FibrosisNCT00180674Imperial College London14
已完成
不适用
Warfarin - How Good Are we at Maintaining Target Range ?Atrial FibrillationNCT01081327University of Dundee5,000
已完成
不适用
Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major BleedHemorrhageNCT02565836Rush University Medical Center342
招募中
不适用
Anticoagulation for Advanced Cirrhotic Patients After TIPSLiver CirrhosisNCT03005444Air Force Military Medical University, China254